Differences in Clinical and Laboratory Features of Pregnant and Non Pregnant Female with Hospitalized COVID 19

Muhana F. Ilyas, Revi G. H. Novika, Winastari Y. Triniputri, I M. E. W. Pradipta, Ni W. P. S. Ksamawati, Nurul J. Wahidah, Hartono Hartono, Lanjar Sumarno

Abstract


Background: The impact of COVID‑19 on vulnerable populations, including pregnant female, is critical due to higher risks and potential complications. This study aims to compare the clinical and laboratory features of COVID‑19 between pregnant and non‑pregnant female.

Materials and Methods: This retrospective cohort study included 245 COVID‑19 patients admitted to Universitas Sabellas Maret (UNS) Hospital, Indonesia, from March 2020 to May 2022. Among them, 72 were pregnant, and 173 were non‑pregnant. Data on demographics, clinical presentations, and laboratory findings were collected from medical records. Statistical analysis utilized Chi‑square or Fisher exact tests, Mann‑Whitney or independent t‑tests, and multiple linear regression.

Results: No significant demographic differences were found, except in hospitalization status. Clinically, pregnant female had a higher prevalence of symptoms such as cough (p = 0.002), fatigue (p = 0.025), and shortness of breath (p = 0.035), with no differences in other symptoms or length of stay. Laboratory findings indicated significant differences in White Cell Count (WCC), Absolute Lymphocyte Count (ALC), High Fluorescence Lymphocyte Count (HFLC), lymphocyte percentage, neutrophil percentage, Neutrophil Lymphocyte Ratio (NLR), Red Cell Count (RCC), Hemoglobin (Hb), Hematocrit (Hct), Platelet Count (PC), Prothrombin Time (PT), International Normalized Ratio (INR), D‑Dimer, and Sodium (p values < 0.05). Multivariate analysis identified WCC, lymphocyte percentage, HFLC, neutrophil percentage, PT, INR, D‑Dimer, Creatinine, and Potassium as significant predictors of length of stay (R²adj = 0.874, F = 17.979, p < 0.001).

Conclusions: Pregnant female with COVID‑19 exhibited distinct laboratory profiles compared to non‑pregnant female. These findings highlight the need for tailored management strategies for COVID‑19 in pregnant patients and provide a foundation for further research.

 


Keywords


COVID‑19, Indonesia, laboratories, pregnancy, signs and symptoms

Full Text:

PDF

References


Chan NN, Ong KW, Siau CS, Lee KW, Peh SC, Yacob S, et al. The lived experiences of a COVID 19 immunization programme: Vaccine hesitancy and vaccine refusal. BMC Public Health 2022;22:296.

Dhasarathan C, Hasan MK, Islam S, Abdullah S, Mokhtar UA, Javed AR, et al. COVID 19 health data analysis and personal data preserving: A homomorphic privacy enforcement approach. Comput Commun 2023;199:87–97.

Lee KW, Gew LT, Siau CS, Peh SC, Chia YC, Yacob S, et al. COVID 19 vaccine hesitancy and its associated factors in Malaysia. PLoS One 2022;17:e0266925.

Yang Z, Wang M, Zhu Z, Liu Y. Coronavirus disease 2019 (COVID 19) and pregnancy: A systematic review. J Matern Fetal Neonatal Med 2022;35:1619–22.

Guan W jie, Ni Z yi, Hu Y, Liang W hua, Ou C quan, He J xing, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20.

Hanardi DYP, Rochmawati E. Tracing management and epidemiological characteristics of close contact COVID 19 in primary health care. Bali Med J 2022;11:1614–9.

Parwanto E, Digambiro RA, Astato E, Guyansyah A. Fatality in a pregnant female with COVID 19 after a cesarean section: A case report. Bali Med J 2022;11:451–4.

Lokken EM, Huebner EM, Taylor GG, Hendrickson S, Vanderhoeven J, Kachikis A, et al. Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am J Obstet Gynecol 2021;225:77.e1 14.

Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al. Update: Characteristics of symptomatic female of reproductive age with laboratory confirmed SARS CoV 2 infection by pregnancy status United States, January 22 October 3, 2020. MMWR Morb Mortal Wkly Rep 2020 Nov 6;69:1641–7.

Surya Akbar TI, Ikhsa M, Dewi RS. Implementation of the blood donation preservation strategy at Indonesian red cross (IRC) blood donor unit (BDU) Banda Aceh during the COVID 19 pandemic. Bali Med J 2022;11:1751–4.

Samprathi M, Jayashree M. Biomarkers in COVID 19: An up to date review. Front Pediatr 2020;8:607647.

Qiancheng X, Jian S, Lingling P, Lei H, Xiaogan J, Weihua L, et al. Coronavirus disease 2019 in pregnancy. Int J Infect Dis 2020;95:376–83.

Xu S, Shao F, Bao B, Ma X, Xu Z, You J, et al. Clinical manifestation and neonatal outcomes of pregnant patients with coronavirus disease 2019 pneumonia in Wuhan, China. Open Forum Infect Dis 2020;7:ofaa283.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506.

Liu Y, Chen H, Tang K, Guo Y. Clinical manifestations and outcome of SARS CoV 2 infection during pregnancy. J Infect 2020;5:1-11.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20.

Wu X, Sun R, Chen J, Xie Y, Zhang S, Wang X. Radiological findings and clinical characteristics of pregnant female with COVID 19 pneumonia. Int J Gynecol Obstet 2020;150:58–63.

Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID 19 patients : A systematic review and meta analysis. J Prev Med Hyg 2020;61:E304–12.

Sutton D, Fuchs K, D’Alton M, Goffman D. Universal screening for SARS CoV 2 in female admitted for delivery. N Engl J Med 2020;382:1–2.

Ilham M, Akbar A, Gumilar KE, Andriya R, Ardian M, Laksana C, et al. Clinical manifestations and pregnancy outcomes of COVID 19 in Indonesian referral hospital in central pandemic area. Obstet Gynecol Sci 2022;65:29–36.

Trocado V, Silvestre Machado J, Azevedo L, Miranda A, Nogueira Silva C. Pregnancy and COVID 19: A systematic review of maternal, obstetric and neonatal outcomes. J Matern Fetal Neonatal Med 2022;35:2362 74.

Maria A, Oliveira SS, Carvalho MA, Nacul L, Cabar FR, Fabri AW, et al. Post viral fatigue following SARS CoV 2 infection during pregnancy: A longitudinal comparative study. 2022. Available from: https://doi.org/10.21203/rs. 3.rs 1629974/v1.

Lamers MM, Haagmans BL. SARS CoV 2 pathogenesis. Nat Rev Microbiol 2022;20:270–84.

Hall J, Hall M, Guyton A. Guyton and Hall Textbook of Medical Physiology. Philadelphia: Elsevier; 2021.

Zha Y, Chen G, Gong X, Wu YY, Lin XG, Wu JL, et al. Coronavirus disease 2019 in pregnant and non pregnant women: A retrospective study. Chin Med J (Engl) 2021;134:1218–20.

Asghar MS, Siddiqui MA, Iqbal S, Avinash, Tahir MJ, Yasmin F, et al. COVID 19 infection among pregnant and non pregnant women: Comparison of biochemical markers and outcomes during COVID 19 pandemic, A retrospective cohort study. Ann Med Surg 2022;76:103527.

Cheng B, Jiang T, Zhang L, Hu R, Tian J, Jiang Y, et al. Clinical characteristics of pregnant women with coronavirus disease 2019 in Wuhan, China. Open Forum Infect Dis 2020;7:ofaa294.

Wang Z, Wang Z, Xiong G. Clinical characteristics and laboratory results of pregnant women with COVID‐19 in Wuhan, China. Int J Gynecol Obstet 2020;150:312–7.

Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil to lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID 19. J Infect 2020;81:e6–12.

Pramono BA, Wiyati PS, Dewantiningrum J. Differences of maternal leukocyte count in premature rupture of membranes and preterm premature rupture of membranes. Bali Med J 2020;9:868–71.

Kadas AS, Okon KO, Chama C, Alkali M, Jibrin YB, Balogun ST, et al. Haematological profile of pregnant female attending antenatal clinic in Bauchi, Nigeria. Open J Obstet Gynecol 2020;10:1776–87.

Taufiqurrahman M, Aditya R. Complete blood count features in pregnant female with Covid 19 confirmed at Ulin Referral Hospital of South Kalimantan. International Teleconference on Technology and Policy for Supporting Implementation of COVID 19 Recovery Plan in Southeast Asia (ITTP COVID19). 2021;(December 2019).

Guo Z, Zhang Z, Prajapati M, Li Y. Lymphopenia caused by virus infections and the mechanisms beyond. Viruses 2021;13:1876.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID 19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420–2.

Azab AE, Albasha MO, Jbireal JM, Yosef S, Hemady E. Haematological changes during pregnancy: Insight into anaemia, leukocytosis, and thrombocytopenia. East Afr Sch J Med Sci 2020;3. doi: 10.36349/EASMS.2020.v03i05.050.

Örgül G, Soyak B, Portakal O, Beksaç M, Beksaç MS. Total blood lymphocyte count alteration during and after pregnancy. Gynecol Obstet Reprod Med 2017;23:11–3.

Myari A, Papapetrou E, Tsaousi C. Diagnostic value of white blood cell parameters for COVID 19: Is there a role for HFLC and IG? Int J Lab Hematol 2022;44:104–11.

Danying Liao, Zhou F, Luo L, Xu M, Wang H, Xia J, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID 19: A retrospective cohort study. Lancet Haematol 2020;7:e671 8.

Morton A. The Continuous Textbook of Female’s Medicine Series – Obstetrics Module Volume 8 Maternal Medical Health and Disorders in Pregnancy. Australia: Obsetric Medicine; 2022. 1–15 p.

Uta M, Neamtu R, Bernad E, Mocanu AG, Gluhovschi A, Popescu A, et al. The influence of nutritional supplementation for iron deficiency anemia on pregnancies associated with SARS CoV 2 infection. Nutrients 2022;14:836.

Chen M, Zeng J, Liu X, Sun G, Gao Y, Liao J, et al. Changes in physiology and immune system during pregnancy and coronavirus infection: A review. Eur J Obstet Gynecol Reprod Biol 2020;255:124–8.

Taneri PE, Gómez Ochoa SA, Llanaj E, Raguindin PF, Rojas LZ, Roa Díaz ZM, et al. Anemia and iron metabolism in COVID 19: A systematic review and meta analysis. Eur J Epidemiol 2020;35:763–73.

Bergamaschi G, Borrelli de Andreis F, Aronico N, Lenti MV, Barteselli C, Merli S, et al. Anemia in patients with Covid 19: Pathogenesis and clinical significance. Clin Exp Med 2021;21:239–46.

Kazma JM, Allegaert K, Ahmadzia HK, George T, Sciences H. Anatomical and physiological alterations of pregnancy Jamil. HHS Public Access 2021;47:271–85.

Russo A, Tellone E, Barreca D, Ficarra S, Lagan G. Implication of COVID 19 on erythrocytes functionality: Red blood cell biochemical implications and morpho functional aspects. Int J Mol Sci 2022;23:2171.

Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, et al. Platelet counts during pregnancy. N Engl J Med 2018;379:32–43.

Mohr Sasson A, Chayo J, Bart Y, Meyer R, Sivan E, Mazaki Tovi S, et al. Laboratory characteristics of pregnant compared to non pregnant female infected with SARS CoV 2. Arch Gynecol Obstet 2020;302:629–34.

Kumar S, Choudhary A, Shukla R, Singh V, Ranjan R. Moderate to severe thrombocytopenia in four pregnant female with asymptomatic COVID 19 infection. Cureus 2021;13:e18531.

Nasir U, Ahmad S. Management and perspective of coronavirus disease 2019 (COVID 19), pregnancy, and hypercoagulability. SN Compr Clin Med 2021;3:1081–4.

Jin X, Duan Y, Bao T, Gu J, Chen Y, Li Y, et al. The values of coagulation function in COVID 19 patients. PLoS One 2020;15:e0241329.

Dorgalaleh A, Favaloro EJ, Bahraini M, Rad F. Standardization of prothrombin time/International Normalized Ratio (PT/INR). Int J Lab Hematol 2021;43:21–8.

Lorini FL, di Matteo M, Gritti P, Grazioli L, Benigni A, Zacchetti L, et al. Coagulopathy and COVID 19. Eur Heart J Suppl 2021;23(Suppl E):E95–8.

Henderson MW, Lima F, Moraes CRP, Ilich A, Huber SC, Barbosa MS, et al. Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID 19. Blood Adv 2022;6:3367–77.

Chauhan AJ, Wiffen LJ, Brown TP. COVID 19: A collision of complement, coagulation and inflammatory pathways. J Thromb Haemost 2020;18:2110–7.

Zhan H, Chen H, Liu C, Cheng L, Yan S, Li H, et al. Diagnostic value of D Dimer in COVID 19: A meta analysis and meta regression. Clin Appl Thromb Hemost 2021;27:10760296211010976.

Siennicka A, Kłysz M, Chełstowski K, Tabaczniuk A, Marcinowska Z, Tarnowska P, et al. Reference values of D dimers and fibrinogen in the course of physiological pregnancy: The potential impact of selected risk factors a pilot study. Biomed Res Int 2020;2020:3192350.

Abou Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID 19: Incidence, pathophysiology, and management. Thromb Res 2020;194:101–15.

Thaker S. Recognizing and avoiding significant maternal hyponatremia. J. South Asian Fed. Obstet 2020;12:100–3.

Ruiz Sánchez JG, Núñez Gil IJ, Cuesta M, Rubio MA, Maroun Eid C, Arroyo Espliguero R, et al. Prognostic impact of hyponatremia and hypernatremia in COVID 19 pneumonia. A HOPE COVID 19 (health outcome predictive evaluation for COVID 19) registry analysis. Front Endocrinol (Lausanne) 2020;11:1–12.

Atila C, Sailer CO, Bassetti S, Tschudin Sutter S, Bingisser R, Siegemund M, et al. Prevalence and outcome of dysnatremia in patients with COVID 19 compared to controls. Eur J Endocrinol 2021;184:413–22.

Diorgu F, Friday CN. Concentration of sodium, potassium, chloride and calcium across trimester of pregnancy. MOJ Women’s Health. 2021;10:1‒3.

di Filippo L, Doga M, Frara S, Giustina A. Hypocalcemia in COVID 19: Prevalence, clinical significance and therapeutic implications. Rev Endocr Metab Disord 2022;23:299–308.

Appelman Dijkstra NM, Ertl DA, Zillikens MC, Rjenmark L, Winter EM. Hypercalcemia during pregnancy: Management and outcomes for mother and child. Endocrine 2021;71:604 10.

Kang J, Hwang S, Lee TS, Cho J, Seo DM, Choi SJ, et al. Gestational age specific serum creatinine can predict adverse pregnancy outcomes. Sci Rep 2022;12:11224.


Refbacks

  • There are currently no refbacks.